Pursuant to Regulation 30 and 33 of SEBI LODR Regulations 2015, we are pleased to furnish the Audited Financial Results along with the Auditors Report for the financial year ended March 31, 2026.
BAYERCROP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.2 pts more than Nifty Smallcap 250 and 2.0 pts more than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Bayer CropScience reported audited results for FY2026 with revenue from operations at ₹56,750 million, up 3.7% from ₹54,734 million in FY2025. Profit after tax grew 21.3% to ₹6,892 million from ₹5,680 million. EPS improved to ₹153.35 from ₹126.38. The company generated strong operating cash flow of ₹10,785 million versus ₹2,620 million in the prior year. Cash and cash equivalents increased significantly to ₹14,146 million from ₹8,855 million. The Board recommended a final dividend of ₹60 per share. The statutory auditors Deloitte Haskins & Sells LLP issued an unmodified opinion on the financial results.
Strong PAT growth of 21% and robust cash generation indicate improved operational efficiency. The stock may see positive reaction given earnings beat potential and healthy dividend payout. The company's EBITDA margin expansion from ~15% to ~17% signals better cost management.